Best Kidney cancer Doctors Worldwide — TOP 131

Prof. Bülent Karagöz specializes in tumor biology and immunotherapy with 33 years of experience of experience, treating kidney cancer at Anadolu Medical Center.

• Head of Medical Oncology at Anadolu Medical Center
• Expertise in targeted therapies and tumor immunology
• Over 40 publications in cancer research
• Professor at Istanbul Okan University Faculty of Medicine
• Member of The Turkish Medical Oncology Association

Ranked 3rd in Turkey for oncology – Dr. Tanrikulu brings precise expertise to kidney cancer treatment at Anadolu Medical Center.

• Specializes in medical oncology with 27 years of experience in the field
• Trained at top institutions including Marmara University
• Led medical oncology units at major teaching hospitals
• Active in international clinical research studies

Dr. Solak brings specialized training from Hacettepe University Cancer Institute and extensive experience with diverse cancers, including kidney cases at Hisar Hospital Intercontinental.

• Specialized in oncology at Istanbul Sisli Etfal Training and Research Hospital
• Fellowship at The University of Texas MD Anderson Cancer Center
• Expertise in gastrointestinal and urologic cancers
• Practices evidence-based protocols from top-tier training

Dr. Banu Atalar is a professor and radiation oncologist at Anadolu Medical Center. She is an Honorary Fellow of the American College of Radiology (H.FACR). She completed a clinical research fellowship in stereotactic radiosurgery at Stanford University. Stereotactic radiosurgery and MR-guided adaptive SRS make up 75% of her clinical practice.

• President of the Turkish Society for Radiation Oncology.
• Chair of the ESTRO National Societies Committee.
• Recipient of the ASCO International Development and Education Award.
• Author of over 70 international peer-reviewed publications.

Head of Oncology at Sourasky Medical Center – Professor Sarid specializes in immunotherapy and targeted therapy for kidney cancer.

• Over 38 years of experience of oncology experience
• Trained in cancer urology at Oxford University
• Principal investigator in clinical trials for new cancer therapies
• Published 30+ articles on oncology treatments
• Member of ESMO and ASCO

Dr. Huseyin Baloglu is a pathologist at Anadolu Medical Center in Turkey. He leads liquid biopsy and precision oncology services. Dr. Baloglu holds a patent for molecular diagnostics in thyroid cancer treatment. He completed training at Albert Einstein College of Medicine and Heidelberg University.

• Authored over 600 peer-reviewed publications in molecular and surgical pathology.
• Specializes in tumor biopsy, immunohistochemistry, and genetic mutation testing.
• Treats complex oncological cases, including glioblastoma and rare sarcomas.
• Works at Anadolu Medical Center, a facility affiliated with Johns Hopkins Medicine.

Prof. Zielinski leads Austria's largest oncology department and founded the Comprehensive Cancer Center Vienna – a global leader in personalized cancer medicine.

• 44 years of experience specializing in medical oncology and immunotherapy
• Head of Vienna Cancer Center and Wiener Privatklinik's International Oncology Center
• Former President of Central European Cooperative Oncology Group (CECOG)
• Pioneer in individualized cancer therapies based on tumor biology

Leading expert in bone and soft tissue oncology at Sourasky Medical Center, with extensive academic and clinical experience in kidney cancer.

• Over 41 years of experience specializing in kidney cancer treatment
• Head of the Soft Tissue and Bone Oncology Unit
• Member of European Society of Medical Oncology (ESMO)
• Active in clinical research and international conferences

Chief physician and professor. Grade 1 Expert at the Cancer Center, West China Hospital, Sichuan University (ranked No. 2 in China). Completed a postdoctoral fellowship in interventional radiology at the Chinese PLA General Hospital. Leads multidisciplinary team (MDT) care for complex tumors. Expert in minimally invasive interventional oncology for liver, lung, and pancreatic cancers.

Accreditations: Council Member, WATA. Member of CACA and CMDA committees on intervention, ablation, radioactive seeds, and pain. In 2023, inaugural director member, Palliative Care Committee, Sichuan MDA. Editorial board member of the Chinese Journal of Interventional Imaging and Therapy. Editorial board member of the Chinese Journal of Pain Medicine.

Leads 2 provincial S&T projects and 2 NSFC projects. Has 40+ papers, with 30+ as first or corresponding author. Highest impact factor: 10.73. Hepatocellular carcinoma (HCC) cohort: TACE + lenvatinib vs TACE + sorafenib. OS 18.97 vs 10.77 months. PFS 10.6 vs 5.4 months. ORR 66.8% vs 33.3%.

Over 3,500 robotic surgeries performed – Dr. Tvaruzek heads the Center of Robotic Surgery at St. Zdislava Hospital.

• Leading certified expert by Intuitive Surgical for the Da Vinci system
• Specializes in prostatectomy with preservation of erectile function
• Member of the Association of Aesthetic Medicine
• Member of the Association of Bariatric Surgery

Dr. Stephanie Lilianne E. Bolle is a radiation oncologist and Head of Radiation Oncology at the Quirónsalud Proton Therapy Center in Madrid. She has led the department since July 2024. The center is Spain’s first proton therapy facility.

MD, University of Liège (1998). Board certified in radiation oncology (2003). She is an active member of the European Society of Paediatric Oncology and works with its Brain Tumor Group and Radiation Oncology Working Group.

She has published more than 120 scientific articles on pediatric brain tumors, proton therapy, pediatric radiation doses, and complex radiotherapy. She takes part in international projects and clinical trials, including BIOMEDE 2 and HARMONIC. Her expertise includes proton therapy, pediatric oncology, CNS and skull base tumors in adults and children, sarcomas, and complex radiotherapy planning.

Specializes in integrative cancer treatments, including mistletoe therapy and high-dose vitamin C, merging conventional and natural approaches.

• Expert in hormonal treatments for breast cancer
• Skilled in managing chemotherapy and radiation therapy side effects
• Experienced in symptomatic and pain relief care for cancer patients
• Participant in international oncology conferences in Germany and Turkey
• Offers natural therapies alongside traditional cancer treatments

Dr. Enrique Grande is a renowned medical oncologist at Hospital Ruber Internacional in Madrid. He has authored over 300 peer-reviewed scientific publications. Dr. Grande focuses on genitourinary and rare endocrine tumors. He serves as a pioneer in precision oncology and molecular profiling.

• Directs the Medical Oncology Department at QuirónSalud.
• Treats complex cases of bladder, kidney, and prostate cancers.
• Contributes to international guidelines for ESMO and ASCO.
• Leads global clinical trials to set new cancer care standards.

Expert in kidney cancer with 17 years of experience as a Consultant Urologist – currently at German Oncology Centre, Cyprus.

• Fellow of the European Board of Urology and Royal College of Surgeons
• Specializes in minimally invasive urologic surgeries
• Active in clinical trials for advanced kidney cancer treatments
• Honorary Senior Lecturer at St Andrews University

Prof. Sezer Sağlam is a leading expert in kidney cancer with over 27 years of experience of specialized practice. He brings extensive experience from prestigious institutions.

• Professor in Medical Oncology since 2016
• Fellowship-trained at Istanbul University – one of Turkey's top medical schools
• Active member of ESMO and ASCO – key oncology associations
• Specializes in complex gastrointestinal oncology cases

Professor Luo Xiaoping is a nationally recognized interventional radiologist and a leading authority in Western China. He began pioneering vascular interventions in the early 1990s. He helped found the Interventional Group at the Second Affiliated Hospital of Chongqing Medical University.

He has completed over 100,000 interventional procedures, including about 4,000 complex cases. His key skills include TACE for hepatocellular carcinoma, Budd–Chiari interventions, TIPS, and single-stage bilateral stenting for hilar biliary obstruction, with success rates near 100%. He has been a master’s supervisor since 2007. He has trained many physicians, guided complex cases at more than 40 major hospitals across Western China, and helped build interventional programs. He has published 32 papers as first or corresponding author (22 CSCD core, 4 Chinese core, 6 CSCD extended).

Dr. He Weibing is a pioneer of argon-helium cryoablation in China with more than 20 years of frontline practice. He was a founding member of Fuda Cancer Hospital (Guangzhou). He co-founded its Minimally Invasive Tumor Treatment Center and served as Executive Deputy Director. He also helped found the Ablation Group of the China Anti-Cancer Association. He has been the primary operator in more than 10,000 procedures.

He specializes in tumor cryoablation and is proficient in 125I seed brachytherapy, with a focus on liver and lung cancers. He proposed ten argon-helium techniques. Key co-authored data include: lung cryotherapy n=508; NSCLC n=120 (CR 25.5%, PR 41.8%, 6/12/24-month survival 64%/55%/36%); pancreatic cancer n=38 (median survival 12 months). He served on editorial boards in 2008 and 2010. He has been a national trainer for Varian and Boston Scientific since 2001.

Specializes in advanced kidney cancer treatments, including targeted therapies and immunotherapy at Liv Bona Dea Hospital Baku.

• 16 years of experience in medical oncology, with a focus on kidney cancer
• Trained at Cleveland Clinic and Istanbul University
• Published multiple studies on cancer treatment outcomes
• Expert in cytotoxic chemotherapy and hormone therapy

Professor Dr. Sefik Igdem specializes in radiation oncology, with advanced expertise in treating kidney cancer using cutting-edge technologies.

• Board-certified in radiation oncology with decades of experience
• Uses Truebeam Stx and Halcyons technologies for precise treatment
• Professor at Demiroğlu Bilim University, training future oncologists
• Focuses on conformal treatments to minimize side effects

Dr. Antonio Alcaraz has performed over 500 successful urological surgeries, many using minimally invasive techniques, at Teknon Medical Center.

• 38 years of experience of experience in urology and kidney transplantation
• Specializes in laparoscopic and robotic-assisted procedures, including Da Vinci system
• Heads the Department of Urology and kidney transplantation
• Member of American Urological Confederation and European Urological Society